Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Operating Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Operating Profit (Excl OI) ₹1,635 Cr₹2,320 Cr₹2,084 Cr₹1,698 Cr₹1,586 Cr

What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?

The latest Operating Profit ratio of GLENMARK PHARMACEUTICALS is ₹1,635 Cr based on Mar2024 Consolidated results.
Year Operating Profit
Mar2024₹1,635 Cr
Mar2023₹2,320 Cr
Mar2022₹2,084 Cr
Mar2021₹1,698 Cr
Mar2020₹1,586 Cr

How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?

Years Operating Profit % Change
Mar2024 ₹1,635 Cr
-29.53
Mar2023 ₹2,320 Cr
11.32
Mar2022 ₹2,084 Cr
22.75
Mar2021 ₹1,698 Cr
7.08
Mar2020 ₹1,586 Cr -

Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,165.8 Cr 15.6% 33.2% 61.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,091.0 Cr 2.3% 3.2% 9.5% Stock Analytics
DIVIS LABORATORIES ₹181,302.0 Cr -0.2% 4.5% 49.6% Stock Analytics
CIPLA ₹119,038.0 Cr -0.2% -2% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹117,170.0 Cr 3.7% 6.5% 16.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,061.0 Cr -0% -4.6% -6.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

15.6%

33.2%

61.6%

SENSEX

-1.1%

1%

3.4%


You may also like the below Video Courses